Myxoid and round-cell liposarcomas share the translocation t(12;16)(q13;p11) creating the TLS-CHOP fusion gene as a common genetic alteration. We previously reported several unique characteristics of genomic sequences around the breakpoints in the TLS and CHOP loci, and among them was the presence of consensus recognition motifs of Translin, a protein that associates with chromosomal translocations of lymphoid neoplasms. We further extended our search for Translin binding motifs in sequences adjacent to breakpoints and investigated whether Translin binds to these sequences in vitro by mobility-shift assay. Computer-assisted search found sequences highly homologous (470%) with Translin binding motifs adjacent to the breakpoints in 10 out of 11 liposarcomas with the TLS-CHOP fusion genes. All of 13 oligonucleotides corresponding to the putative binding sequences in these cases bind to Hela cell extract and also recombinant Translin protein, although the binding anity of each motif showed considerable dierences. The DNA-protein complex formation was inhibited by non-labeled competitor or anti-Translin antibody, suggesting the speci®city of the complex formation. Considering the high incidence and speci®c binding property, the presence of Translin binding motif may be one of the important determinants for the location of breakpoints in the TLS and CHOP genes in liposarcomas. Oncogene (2000) 19, 5821 ± 5825.
Myxoid and round-cell liposarcomas share the translocation t(12;16)(q13;p11) creating the TLS-CHOP fusion gene as a common genetic alteration. We previously reported several unique characteristics of genomic sequences around the breakpoints in the TLS and CHOP loci, and among them was the presence of consensus recognition motifs of Translin, a protein that associates with chromosomal translocations of lymphoid neoplasms. We further extended our search for Translin binding motifs in sequences adjacent to breakpoints and investigated whether Translin binds to these sequences in vitro by mobility-shift assay. Computer-assisted search found sequences highly homologous (470%) with Translin binding motifs adjacent to the breakpoints in 10 out of 11 liposarcomas with the TLS-CHOP fusion genes. All of 13 oligonucleotides corresponding to the putative binding sequences in these cases bind to Hela cell extract and also recombinant Translin protein, although the binding anity of each motif showed considerable dierences. The DNA-protein complex formation was inhibited by non-labeled competitor or anti-Translin antibody, suggesting the speci®city of the complex formation. Considering the high incidence and speci®c binding property, the presence of Translin binding motif may be one of the important determinants for the location of breakpoints in the TLS and CHOP genes in liposarcomas. Oncogene (2000) 19, 5821 ± 5825.
Keywords: Translin; liposarcoma; translocation; mobility-shift assay Reciprocal chromosomal translocations are one of the common genetic alterations found in human neoplasms. Oncogenic property of these genetic alterations is provided by the activity of a new gene which is created by combining a part of whole of the target genes on each chromosome (Rabbitts, 1994) . Spectrum of tumors harboring this type of mutations has extended from hematopoietic malignancies to solid tumors, including myxoid liposarcomas (Crozat et al., 1993; Rabbitts et al., 1993) . The translocations t(12;16) in myxoid liposarcomas create a fusion gene composed of the amino-terminal portion of the TLS/FUS gene (hereafter called simply TLS) on chromosome 16 and the entire coding portion of the CHOP gene on chromosome 12 (Crozat et al., 1993; Rabbitts et al., 1993) . Recent studies have gradually disclosed the roles of fusion genes in the development of neoplasms, but little is known concerning the process of translocation itself. Recently, we reported the precise analysis of genomic breakpoints of the TLS and CHOP genes in liposarcomas, and found that sequences around the breakpoints have a homology with consensus binding motifs for several factors involved in the DNA recombination (Kanoe et al., 1999) . Among them was Translin, which was originally isolated as a protein binding to a common sequence motif at the 5'¯anking region of breakpoints in 91 lymphoid malignancies consisted of 16 dierent types (Aoki et al., 1995) . Following studies have revealed that similar motif also existed at the breakpoints in several other neoplasms with reciprocal translocations speci®c for each type of tumor, such as chronic myeloid leukemia, acute myeloid leukemia, and alveolar rhabdomyosarcoma (Atlas et al., 1998; Jes et al., 1998; Chalk et al., 1997) . However, the location relative to the breakpoints and the degree of homology with consensus sequences varied considerably among each`putative Translin binding sequence', making it dicult to compare the results of dierent studies. In addition, regions to be searched for Translin binding motif are also to be de®ned. As in the original study in lymphoid malignancies, following studies concentrated on the analysis of the sense strand sequences around the breakpoints to ®nd Translin binding motifs (Atlas et al., 1998; Jes et al., 1998; Chalk et al., 1997) . However, Translin was shown to bind single strand DNA (Kasai et al., 1997) , which will be created as a staggered end after chromosomal breakage. Such chromosomal breakage may take place in the 3' side gene as well as the 5' side gene, suggesting that the antisense strand of the 3' side gene should be included for the analysis as well as the sense strand of 5' side gene.
Considering these points, we investigated the signi®cance of Translin in the development of the TLS-CHOP fusion genome by intensively searching the candidate sequences around the breakpoints, and examined the property of such sequences to bind to Translin in vitro by mobility-shift assay. In the previous report, we have determined genomic breakpoints in the TLS and CHOP genes in 10 liposarcomas with the TLS-CHOP fusion transcript (Kanoe et al., 1999) . In addition to these cases, one case was included in this study (KS559), of which the fusion transcript showed that type I structure containing exon 7 of the TLS gene followed by exon 2 of the CHOP gene (Panagopoulos et al., 1994) (data not shown). Both of the TLS-CHOP and CHOP-TLS genomic fragments encompassing the fusion points were ampli®ed, cloned and sequenced to determine the precise breakpoints in each locus as previously reported (Kanoe et al., 1999) . Including this case, we have determined both of the TLS-CHOP and CHOP-TLS breakpoint sequences in seven cases, and the TLS-CHOP breakpoint sequences in four cases. Therefore, 18 breakpoint sequences were able to be analysed for the presence of Translin binding motif. As previously reported, some of these breakpoints contained a deletion or insertion at the junction (Kanoe et al., 1999) , and the original breakpoint sequences of each TLS and CHOP locus were analysed in such cases. In this study the following criteria were used to ®nd putative Translin binding sequences: (1) 3' end of such sequences should be within 5 bp-distance, either 5' or 3', from the breakpoint, because most of Translin binding motifs reported in the original study existed at the 5'¯anking site of breakpoints (Aoki et al., 1995) ; (2) homology with Translin binding motifs should be more than 70%; (3) searching regions include the sense strand of 5' side gene and antisense strand of 3' side gene adjacent to the breakpoints. Two consensus Translin binding motifs, (i) 5'-ATGCAG (0 ± 4 bp) GCCC (A/T) (G/C) (G/C) (A/T)-3' and (ii) 5'-GCNC (A/T) (G/C) CT (0 ± 2 bp) GCCC (A/T) (G/C) (G/C) (A/T)-3' were used to ®nd candidate sequences (Aoki et al., 1995) , and the homology with these consensus sequences was analysed initially by the computer software (GENETYX MAC, Software Development Co., Tokyo, Japan), and con®rmed by two authors (T Hosaka and J Toguchida).
Using the above mentioned criteria, we found a sequence homologous to Translin binding motifs in 10 out of 11 liposarcoma cases (Table 1 ). Among seven cases in which both of the TLS-CHOP and CHOP-TLS breakpoints were able to be analysed, two cases (KS410 and KS559) had a Translin binding motif at both breakpoints, and four cases had a Translin binding motif at either one of the two breakpoints. No sequence with a homology more than 70% with Translin binding motifs was found in the last case (KS376). In other four cases, only the TLS-CHOP breakpoint was able to be analysed, and all of them had a Translin binding motif at the breakpoints. In one of them, KS180, two putative sequences were found in the searched region of the sense strand of the TLS gene in the TLS-CHOP fusion genome. This is the only case which had a breakpoint within the coding sequence (Exon 5 of the TLS gene) (Kanoe et al., 1999) , and the breakpoint was found in the middle of a complete 18 bp tandem repeat (GGACAGCAGCAAAGCTAT), which itself has a homology (75%) with a Translin binding motif. Therefore, 13 dierent Translin binding motifs were found in 18 breakpoints (Table 1) . Considering the diversity of consensus sequences and setting the homology as more than 70%, Translin binding motifs are expected to be present in once in 57.1 bases. Therefore, the expected number of Translin binding motifs in the searched regions (396 bases; 18 breakpoints 6 2 strands 6 11 bases) is 6.93, which is lower than the observed number with a statistical signi®cance (P50.025). The incidence of Translin binding motif on each strand showed the highest value at the antisense strand at the TLS-CHOP breakpoints (7/11, 63.6%), followed by the sense strand of the CHOP-TLS breakpoints (2/7, 28.6%), the sense strand of the TLS-CHOP breakpoints (2/11, 18.1%), and the antisense strand of the CHOP-TLS breakpoints (1/7, 14.3%) ( Table 1) . No case had a Translin binding motif in both sense and antisense strands at each breakpoint.
To determine whether these homologous sequences have a property to bind to Translin, single-stranded 24-mer ONDs corresponding to these sequences were synthesized, and per cent homology with consensus sequences ranged from 71 to 81% (Table 2) . Each OND was radio-labeled and subjected to mobilityshift assay with cytosolic fraction of Hela cells, which was shown to contain Translin protein (Aoki et al., 1995) . DNA-protein complex was detected in all 13 ONDs as well as the positive control OND (BCL6), although the binding anity seemed to be dierent among them (Figure 1a) . The binding anity of 559CA seemed to be equivalent with that of the positive control. On the other hand, two bands were detected in the case of 282TS, 559TA, 227CA and 427CA. In the later two cases, the intensity of the faster migrated bands was much stronger than that of the bands comigrated with the positive control band, suggesting that these ONDs may make a complex with other proteins in addition to Translin with better anity. Binding anity of each OND was also analysed using the recombinant Translin, and all 13 OND, were proved to bind the recombinant Translin (Figure 1b) . Similar to the results using cytosolic protein, the ecacy of complex formation was dierent among them. However, the relative anity of each OND with recombinant Translin seemed to be similar to those with cytosolic protein, with one exception, 509CA, which showed much strong anity with cytosolic Translin. Two ONDs, 227CA and 427CA, which showed a strong anity with other cytosolic protein, also formed a complex with the recombinant Translin with relatively lower anity. There is not a strong correspondence between the anity of each OND and the degree of homology with the consensus sequence.
Speci®city of binding was examined by adding nonlabeled ONDs as a speci®c competitor, and representative results were shown using an OND of 282TS (Figure 2 ). The formation of labeled OND-protein complex was gradually reduced in proportion to the amount of non-labeled ONDs (Figure 2a ). This reduction was not observed when a non-speci®c, nonlabeled OND (MPR2PR1) was incubated together as a competitor (Figure 2a) . Speci®city of complex formation was further examined by the incubation with either anti-Translin antibody or non-speci®c rabbit IgG. Epitope of Translin recognized by anti-Translin antibody exists in or near its DNA-binding site, and therefore anti-Translin antibody is supposed to prevent Translin from binding to OND in mobility-shift assay (Aoki et al., 1995) . Reduction of binding was seen in a dose-dependent manner, when anti-Translin antibody was incubated together in the reaction, but the binding of OND to Translin was not inhibited by non-speci®c rabbit IgG (Figure 2b) . Identical results were obtained in the analyses of other 12 ONDs (data not shown).
Elucidation of mechanisms underlying the chromosomal translocations is becoming a more important issue in the ®eld of cancer research, because of the recent spectrum expansion of tumors with this type of genetic alteration (Rabbitts, 1994) . The present study showed that in the case of liposarcomas with the TLS-CHOP fusion transcript, putative Translin binding motif was frequently present adjacent to the breakpoints. All of these putative motifs were found to make a complex with cytosolic protein and the recombinant Translin in vitro. Although the binding anity of each motif seemed to be dierent, the inhibition of binding by competitors and anti-Translin antibody may indicate that the complex formation was speci®c to Translin. Because we failed to observe apparent correlation between the binding anity and the degree of homology with the consensus sequence, it is likely that there are some unde®ned characteristics in these sequences that may determine the anity. Although Translin binding motifs are present in the human genome with a relatively high frequency (once in 57.1 bases, if the homology is de®ned as 470%), the observed number of Translin binding motifs around the breakpoints in this study was statistically higher than the expected number. These results suggest that the association of Translin binding motif with the breakpoints is not a random event, and Translin may play some role in the development of the TLS-CHOP fusion genome. 
KS287
(1) Recent studies have shown that Translin is a multifunctional protein involved in several biologically important processes. Translin was transiently transported from the cytoplasm to the nucleus after the treatment with the DNA-damaging agents such as mitomycin C or etoposide (Kasai et al., 1997) . The TB-RBP (testis-brain RNA binding protein), mouse homologue of Translin, was shown to suppress translation and attach mRNAs to microtubules by binding to conserved elements in the 3' untranslated regions of a number of testicular and brain mRNAs (Wu et al., 1997) . More recently, sequences with highly Pellets were washed twice in ice-cold PBS, resuspended with 400 ml of hypotonic buer [10 mM HEPES-KOH (pH 7.8), 10 mM KCl, 0.1 mM EDTA, 0.1% NP-40, 1 mM DTT, 0.5 mM PMSF, 2 mg/ml Aprotinin, 2 mg/ml Pestatin, 2 mg/ml Leupeptin] and incubated on ice for 10 min. After centrifugation at 2000 g for 5 min, the supernatants were supplemented with KCl to 100 mM and glycerol to 10%, and saved as the cytosolic fraction. Single stranded ONDs listed in Table 1 were synthesized, endlabeled with g-32 P-ATP using T4 polynucleotide kinase (TaKaRa, Kyoto, Japan) and puri®ed by nucleotide puri®cation column (QIAGEN, CA, USA). As a positive and negative control OND in mobility-shift assay, BCL6 (5'-CTGCACCTGCGATGCCTTT-CAGTG-3') and MPR2PR1 (5'-CTATAGAATTCT-CAAGCTTGC-3') are used, respectively (Aoki et al., 1995; Wu et al., 1997) . 7 mg of cytosolic fraction of Hela (a) or 30 ng of recombinant Translin (b) were incubated at room temperature for 20 min with 10 pg of 32 P-labeled ONDs in 20 ml of binding buer [10 mM Tris-HCl (pH 7.5), 50 mM NaCl, 1 mM EDTA, 1 mM DTT, 5% glycerol, 4 mg of poly(dI-dC)(dI-dC)]. DNA-protein complexes were separated on a 5% non-denaturing polyacrylamide gel in TBE buer (89 mM Tris, 89 mM boric acid, 2.5 mM EDTA) at room temperature. The gel was then dried and autoradiographed. Lane 1, BCL6 (positive control); lane 2, MPR2PR1 (negative control); lanes 3 ± 15, ONDs from the breakpoint sequences loaded as the order in Table (Table 2) was incubated with recombinant Translin with increasing amount (0.01 to 1 pmol) of non-labeled OND of 282TS or with nonlabeled non-speci®c OND (MPR2PR1), and the binding was analysed by mobility-shift assay. (b) Inhibition by anti-Translin antibody. 32 P-labeled OND of 282TS was incubated with Hela cell cytosolic fraction with increasing amount (0.05 ± 0.3 mg) of anti-Translin antibody or with 0.3 mg of rabbit IgG, followed electrophoretic analysis on a 5% non-denaturing polyacrylamide gel homologous to the consensus Translin binding motifs were found in the hotspot region of meiotic recombination (Badge et al., 2000) . These possible roles in the DNA repair system, translational regulation, and meiotic recombination suggest that Translin is a reasonable candidate as one of the important factors involved in the development of chromosomal translocation.
Several models have been proposed to explain the mechanism of reciprocal chromosomal translocation (Szostak et al., 1983; Roth et al., 1995; Zucman-Rossi et al., 1998) . We previously reported that deletions or duplications were frequently found as additional genetic alterations in the development of the TLS-CHOP fusion genome (Kanoe et al., 1999) . A similar result was also reported in the study of t(11;22) in the Ewing's sarcoma and t(4;11) in the acute pro-B cell leukemia, suggesting that primary event is the generation of the double-strand-break producing a staggered end and DNA repair mechanisms are involved to produce such genetic alterations (Zucman-Rossi et al., 1998; Gillert et al., 1999) . In this context, it is intriguing that the consensus binding motifs of topoisomerase IIa, which is supposed to create double-strand-break in the process of DNA repair (Burden and Oshero, 1998) , were found nearby the breakpoints in all cases with a deletion or duplication as an additional genetic alteration (Kanoe et al., 1999) . These results suggest that the factors involved in the DNA repair system such as Translin and topoisomerase II may also be involved in the development of chromosomal translocation. It is an intriguing fact that no cases in this study were proved to have a Translin binding motif on both of the sense and antisense strand. Presence of Translin binding motif in one of two staggered ends might be sucient for enrolling Translin at the breakpoints.
We showed that liposarcoma is the second solid tumor next to rhabdomyosarcoma (Chalk et al., 1997) , of which the breakpoint sequences are shown to bind Translin by mobility-shift assay. In the case of Ewing's sarcoma, two recent studies denied the presence of Translin binding motifs at the breakpoints (ZucmanRossi et al., 1998; Obata et al., 1999) . However, by the de®nition used in this study, there are several Translin binding motifs with a high homology around the breakpoints in the published cases, and at least one OND synthesized from such sequence was found to bind to Translin by mobility-shift assay (data not shown). Therefore, intensive survey of Translin binding motifs in other types of translocations such as SYT-SSX in synovial sarcomas would be an intriguing issue to investigate.
